Mobia Medical’s (MOBI) Buy Rating Reiterated at BTIG Research

BTIG Research restated their buy rating on shares of Mobia Medical (NASDAQ:MOBI) in a report issued on Wednesday morning,Benzinga reports. They currently have a $19.00 target price on the stock.

A number of other research analysts have also weighed in on the stock. Wall Street Zen raised shares of Mobia Medical from a “sell” rating to a “hold” rating in a research note on Sunday, June 14th. JPMorgan Chase & Co. began coverage on Mobia Medical in a research report on Tuesday, June 2nd. They set an “overweight” rating and a $15.00 price target for the company. Zacks Research upgraded Mobia Medical to a “hold” rating in a research note on Wednesday, June 3rd. Bank of America began coverage on Mobia Medical in a research report on Tuesday, June 2nd. They set a “buy” rating and a $16.00 price target on the stock. Finally, Wolfe Research assumed coverage on Mobia Medical in a research note on Tuesday, June 2nd. They set an “outperform” rating on the stock. Five research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $20.75.

Mobia Medical Price Performance

NASDAQ MOBI opened at $11.76 on Wednesday. The stock’s 50 day simple moving average is $12.44. The company has a debt-to-equity ratio of 0.04, a quick ratio of 5.55 and a current ratio of 13.28. Mobia Medical has a one year low of $10.19 and a one year high of $15.29. The company has a market cap of $391.50 million and a price-to-earnings ratio of -0.61.

Mobia Medical (NASDAQ:MOBI) last announced its quarterly earnings data on Tuesday, August 11th. The company reported ($1.10) earnings per share for the quarter, missing the consensus estimate of ($0.83) by ($0.27). The business had revenue of $13.51 million during the quarter. The company’s quarterly revenue was up 102.4% compared to the same quarter last year. As a group, equities analysts expect that Mobia Medical will post -2.64 earnings per share for the current year.

Insider Activity

In related news, CFO Nelson Bunker Curnes acquired 5,000 shares of the stock in a transaction dated Tuesday, June 9th. The stock was bought at an average cost of $12.79 per share, for a total transaction of $63,950.00. Following the completion of the transaction, the chief financial officer directly owned 366,997 shares of the company’s stock, valued at $4,693,891.63. The trade was a 1.38% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Mobia Medical Company Profile

Mobia Medical Inc is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. Mobia Medical Inc is based in AUSTIN, Texas.